(1 - 29 von 35
)
Anavex CEO Christopher Missling sells $375k in company ...Investing.com
www.investing.com
— (NASDAQ:AVXL) President and CEO Christopher Missling, several metrics and InvestingPro Tips provide additional context. Anavex holds more cash — (NASDAQ:AVXL) President and CEO Christopher Missling, several metrics and InvestingPro Tips provide additional context. Anavex holds more cash ...
Anavex President's Concealment Cost Company Millions, ...Bloomberg Law News
news.bloomberglaw.com
vor 2 Tagen — Anavex Life Sciences Corp.'s Chief Executive Officer Christopher Missling and company directors were hit with a shareholder derivative ... vor 2 Tagen — Anavex Life Sciences Corp.'s Chief Executive Officer Christopher Missling and company directors were hit with a shareholder derivative ...
Anavex confirms board members, ratifies auditor at annual ...Investing.com
www.investing.com
vor 20 Stunden — Christopher Missling, highlighted the positive trends in clinical trials and the potential for blarcamesine to offer improved safety and ... vor 20 Stunden — Christopher Missling, highlighted the positive trends in clinical trials and the potential for blarcamesine to offer improved safety and ...
Precision in Clinical Trials Virtual Summit (West Coast)Industry Events
www.industryevents.com
Christopher Missling. President & CEO Anavex Life Sciences Corp. View Profile. Courtney Bryant. Sr. Director Business Operations Moderna. View Profile. Craig ... Christopher Missling. President & CEO Anavex Life Sciences Corp. View Profile. Courtney Bryant. Sr. Director Business Operations Moderna. View Profile. Craig ...
Unser Partner - Der VVWL e.V.Kompetenznetz Logistik.NRW
www.logit-club.de
Herr Christopher Missling Kompetenzbereich Human Resources missling(at)vvwl.de. Herr Andreas Stommel Kompetenzbereich Schifffahrt-, Hafen und ... Herr Christopher Missling Kompetenzbereich Human Resources missling(at)vvwl.de. Herr Andreas Stommel Kompetenzbereich Schifffahrt-, Hafen und ...
Deutsches Biotech-Start-up geht an die Nasdaq - Anavex ...EQS News
www.eqs-news.com
— Der Deutsche Biotech-Unternehmer und Investmentbanker Dr. Christopher Missling sorgt derzeit in der US-amerikanischen Biotech-Szene für Furore — Der Deutsche Biotech-Unternehmer und Investmentbanker Dr. Christopher Missling sorgt derzeit in der US-amerikanischen Biotech-Szene für Furore.
Fragile X Mouse Model Signaling Pathways Normalize ...Fragile X News Today
fragilexnewstoday.com
— ... Christopher Missling, PhD, president and CEO of Anavex, said in a press release. “We look forward to initiating a double-blind, placebo — ... Christopher Missling, PhD, president and CEO of Anavex, said in a press release. “We look forward to initiating a double-blind, placebo ...
ImmunoGen Appoints Lauren White As CFORTTNews
www.rttnews.com
— ... Christopher Missling when he resigned in January ... She will be succeeding interim finance chief Karleen Oberton, who took over from Christopher — ... Christopher Missling when he resigned in January ... She will be succeeding interim finance chief Karleen Oberton, who took over from Christopher ...
Why Shares of Anavex Life Sciences Rose 12.4% in ...The Globe and Mail
www.theglobeandmail.com
— In its earnings report, company CEO Christopher Missling said the company was pleased with the progress of Anavex (blarcamesine) in a ...
AVXL.O - Anavex Life Sciences Corp | Stock Price & Latest News |...
www.reuters.com
Connect to the most current information on stocks and bonds on Reuters.com for AVXL.O
SEE Private Equity Group S.A., APA-OTS
www.ots.at
— Christopher Missling, Partner der New Yorker Investmentbank Brimberg & Co. Technologische Alternativen im Bereich erneuerbare Energie als ...
Christopher Missling, MS, PhD, MBA, is Now CEO of Anavex Life...
www.twst.com
9. Nov · November 9, Christopher U. Missling, M.S., Ph.D., MBA, is the President and CEO of Anavex Life Sciences Corp. Dr. Missling has over 20 years of health care industry experience within large ...
Vorsicht bei Anavex Life Sciences Wallstreet Online
www.wallstreet-online.de
— Gerade mal rund 12 Prozent der Aktien sind im Besitz von Großaktionären, 3,33 Prozent davon gehören CEO Christopher Missling und 4,
Anavex Life Sciences' CEO Christopher Missling on Q Results
news.futunn.com
DJ Anavex Life Sciences' CEO Christopher Missling on Q Results -- Earnings Call Transcript >AVXL From Seeking Alpha: Anavex Life Sciences' CEO...
SVG-Personal-Pakt® - Informiert!Tag der Logistik
www.tag-der-logistik.de
Christopher Missling und Marcus Hover berichten zum Min- destlohn und zum. Kraftfahrermangel! Page 3. Das Motto „Deine Zukunft - Mit Sicherheit“ sollte unseren ...
Experten klären über Maut und Ruhezeiten auf | VerkehrsRundschau.de
www.verkehrsrundschau.de
Die VerkehrsRundschau lädt zum kostenlosen Logistik-Networking ein. Namhafte Referenten beantworten an sechs Terminen in sechs Städten...
Alzheimer Patients in Anavex Trials May Still Use Therapy in...
alzheimersnewstoday.com
Australia is letting people who took part in Phase 2 studies of Anavex Life Sciences' therapy continue using it at their doctor's request.
Anavex Life Sciences advancing its Parkinson's disease ...Proactive Investors
www.proactiveinvestors.com
— Anavex Life Sciences Corp (NASDAQ:AVXL) President and CEO Christopher Missling sat down with Proactive Investors at the BIO CEO & Investor ...
Anavex Presents Positive Initial Phase 2a Study Data With
www.globenewswire.com
... Cecchi, Dennis Moore, Anastasios Zografidis and Christopher Missling and is available on the publications page of the Anavex website.
Anavex sets up trial of 'triple-action' Alzheimer's drugPMLiVE
www.pmlive.com
— Christopher Missling. The company has said it intends to select patients for inclusion into that study based on genomic biomarkers ...
Anavex touts topline data for Alzheimer's drug trial | BioPharma Dive
www.biopharmadive.com
BioPharma
Deutsche Balaton AG: Unternehmensmitteilung der Deutsche Balaton AG...
www.deutsche-balaton.de
Herr Dr. Christopher Missling, President & Chief Executive Officer sowie Chairman of the Board der Anavex Life Science Corp., eines an der ...
Long-term Anavex reduced dementia, motor symptomsParkinson's News Today
parkinsonsnewstoday.com
— ... an urgent unmet global need,” Christopher Missling, PhD, the president and CEO of Anavex Life Sciences, the therapy's developer, ...
Intellus Worldwide Summit - Philadelphia — The Jansen's Foundation
www.thejansensfoundation.org
Drug development is spurred when unmet need and science come together.
Strategic planning, focus and drive can spur the birth of new treatments
and change....
Notierungsaufnahme für Deutsches Biotech-Startup an der ...EQS News
www.eqs-news.com
— Als CEO von Anavex Life Sciences Corp. ist Dr. Christopher Missling derzeit ferfolgreich am US-Biotech-Biotechmarkt unterwegs. Mit der nun ...
Relief from Rett?Drug Discovery News
www.drugdiscoverynews.com
— ... we decided to explore Anavex in Rett syndrome,” Christopher Missling, CEO of Anavex, tells DDNews. “Recent third-party publications ...
aktiencheck.de AG: Deutsches Biotech-Start-up geht an die ...www.dgap.de › dgap › News › corporate › aktiencheckde-deutsches-bio...
www.dgap.de
Der Deutsche Biotech-Unternehmer und Investmentbanker Dr. Christopher Missling sorgt derzeit in der US-amerikanischen Biotech-Szene für ...
sortiert nach Relevanz / Datum